View Older Stories View More Recent Stories
-
Bank of Montreal, CaixaBank, Commerzbank, Erste Group, IBM and UBS Collaborate to Advance an Open, Blockchain-based Trade Finance Platform
-
UPDATE: Rigel Pharma (RIGL) to Offer Up to $40M in Common Stock
-
National Storage Affiliates Trust Announces Pricing of Public Offering of $150 Million of 6.000% Series A Cumulative Redeemable Preferred Shares
-
Rigel Announces Proposed Public Offering Of Common Stock
-
UPDATE: Rigel Pharmaceuticals (RIGL) PT Raised to $6 at BMO Capital; Fostamatinib Probability of Success Increases
-
BMO Capital Downgrades C.H. Robinson Worldwide (CHRW) to Market Perform
-
AltaGas Ltd. Announces Aggregate $450 Million Medium-Term Note Offerings
-
Nightstar Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
-
Manpower Inc. (MAN) PT Raised to $132 at BMO Capital Following Recent Management Meetings; 'France and Italy Have Been Key Recent Growth Drivers'
-
ICR Announces Sponsors of 20th Anniversary Event
-
Streetwise Reports Examines A'Production Ramp-Up That Is Progressing Strongly' and Garners an Outperform Rating
-
BMO Capital Starts Micron Technology (MU) at Market Perform
-
Ionis Pharmaceuticals (IONS) Selling Pressure 'Unwarranted' - BMO
-
Accenture plc (ACN) PT Raised to $140 at BMO Capital on 4Q Report; 'Solid Quarter... Remains Well Positioned in Industry'
-
BMO Capital Downgrades Norbord (OSB) to Underperform
-
BMO Capital Downgrades Louisiana-Pacific Corp (LPX) to Underperform
-
Nightstar Therapeutics plc (NITE) IPO Opens Up 23%
-
Actuant (ATU) PT Raised to $25 at BMO Capital on 4Q Report; 'Trends a Bit Better, Recovery Looks Slow-Paced'
-
Thor Industries Inc. (THO) PT Raised to $135 at BMO Capital on 4Q Report; ' Hammers Estimates, Jayco Contributing More Than Anticipated'
-
Financial 15 Split Corp. Completes Overnight Offering of $79,109,100
-
AveXis (AVXS): AVXS-101 Abstracts Could Highlight The Next Driver - BMO
-
Nightstar Therapeutics PLC (NITE) Prices 5.36M ADS IPO at $14/Sh
-
DexCom (DXCM) PT Lowered to $62 at BMO Capital
-
BMO Capital Downgrades Arista Networks (ANET) to Market Perform
-
Nightstar Announces Pricing of Initial Public Offering
-
IHS Markit (INFO) PT Lowered to $50 at BMO Capital on 3Q Reports; 'Near-Term Headwinds, Long-Term Investments'
-
Darden Restaurants (DRI) PT Lowered to $85 at BMO Capital on 1Q Report; 'Softer SSS & Margins Offset a Lower Tax Rate'
-
Chipotle Mexican Grill (CMG) PT Lowered to $330 at BMO Capital on Informal NYC Queso Survey; 'Comp Light Below Investor Expectations'
-
Urstadt Biddle Properties Inc. Announces Closing of Over-Allotment Option for Series H Preferred Stock Offering
-
Life & Banc Split Corp. Announces Successful Overnight Offering
-
Mattamy Group Corporation Announces Results of Cash Tender Offers For Any and All of its Outstanding 6.500% Senior Notes due 2020 and 6.875% Senior Notes due 2020 and Issuance of Notices of Redemption
-
Red Hat (RHT) PT Raised to $128 at BMO Capital
-
IRET Announces Pricing of Public Offering of 6.625% Series C Cumulative Redeemable Preferred Shares
-
Sabra Health Care REIT (SBRA) Prices 16M Share Common Offering at $21/Sh
-
BMO Capital Starts Cheniere Energy Partners LP Holdings (CQH) at Market Perform
-
UPDATE: BMO Capital Starts Cheniere Energy Partners, LP (CQP) at Outperform
-
UPDATE: BMO Capital Starts Cheniere Energy (LNG) at Outperform
-
Sabra Health Care REIT Prices Public Offering of 16,000,000 Shares of Common Stock
-
Sabra Health Care REIT (SBRA) Plans 16M Common Stock Offering
-
Sabra Health Care REIT Announces Public Offering of 16,000,000 Shares of Common Stock
-
Intercept Pharma (ICPT) Price Target $160 Maintained at BMO Capital
-
Mitel Networks (MITL) Completes Acquisition of ShoreTel (SHOR)
-
Mitel Completes Acquisition of ShoreTel
-
IRET Announces Public Offering of Series C Cumulative Redeemable Preferred Shares
-
Cenovus Energy (CVE) to Sell Suffield Assets for $512M
-
Cenovus reaches agreement to sell Suffield assets for more than half a billion dollars
-
Intercept Pharmaceuticals (ICPT) PT Lowered to $160 at BMO Capital After FDA Outlines Ocaliva SAE
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $134 at BMO Capital; Makes Case for $165 Upside Scenario
-
Texas Instruments (TXN) PT Raised to $105 at BMO Capital on "Long-Term Earnings Power and FCF Generating Ability"
-
Newell Rubbermaid (NWL) PT Lowered to $45 at BMO Capital; 'Lowering FY18 EPS Estimate'


